Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RCHY1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | VAMP2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | MRGBP | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | SLC24A3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | ZC3H12B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | TBC1D10B | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | HNRNPU | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | FBRSL1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | LIPT2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | PRKAA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |